Indeed, recent data reported that neutralizing anti-IFN-I aAbs (against IFN-α2 alone or with IFN-ω) can be involved in critical influenza pneumonia, as they are present in about 5% of cases of life-threatening respiratory infections. Here, IFNA2 is linked to pneumonia.